Propofol (Group P) for Anesthesia

"Clinicaltrials.gov states that this experiment is not presently recruiting patients, having first been posted on May 11th 2018 and last updated on August 16th 2022. Despite the lack of current enrollment, there are still 299 other trials currently open for participation across multiple sites."

"Propofol combined with Dexmedetomidine (Group DP) is the most popular therapeutic approach for sedative therapy. Such a combination can also be beneficial in treating additional maladies such as anaesthesia protocols, medical procedure-related sedation and afflictions."

"The prerequisites for this trial indicate that the ideal candidate should be aged between 7 and 18. There are presently 75 trials aimed at minors, while 209 studies focus on individuals above 65 years old."

"For this study, 39 minors aged 7 to 18 years old who are due for upper or lower endoscopic procedures at Boston Children's Hospital and meet the criteria necessary to receive dexmedetomidine or propofol sedation must apply. The application requires written consent from both parents and patient."

"This clinical trial is not currently enrolling. It was initially disclosed on May 11th, 2018 and was last changed on August 16th 2022. Those looking for other studies can find 126 anaesthesia therapy trials actively recruiting as well 173 Propofol with Dexmedetomidine (Group DP) studies in search of participants."

"Group DP, a combination of Propofol and Dexmedetomidine, has been officially authorized for medical use; thus the safety rating was set to 3."